NEK4_HUMAN - dbPTM
NEK4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NEK4_HUMAN
UniProt AC P51957
Protein Name Serine/threonine-protein kinase Nek4
Gene Name NEK4
Organism Homo sapiens (Human).
Sequence Length 841
Subcellular Localization Cell projection, cilium . Cytoplasm .
Protein Description Protein kinase that seems to act exclusively upon threonine residues (By similarity). Required for normal entry into proliferative arrest after a limited number of cell divisions, also called replicative senescence. Required for normal cell cycle arrest in response to double-stranded DNA damage..
Protein Sequence MPLAAYCYLRVVGKGSYGEVTLVKHRRDGKQYVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNIVTYKESWEGGDGLLYIVMGFCEGGDLYRKLKEQKGQLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENHCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPRDYSPELAELIRTMLSKRPEERPSVRSILRQPYIKRQISFFLEATKIKTSKNNIKNGDSQSKPFATVVSGEAESNHEVIHPQPLSSEGSQTYIMGEGKCLSQEKPRASGLLKSPASLKAHTCKQDLSNTTELATISSVNIDILPAKGRDSVSDGFVQENQPRYLDASNELGGICSISQVEEEMLQDNTKSSAQPENLIPMWSSDIVTGEKNEPVKPLQPLIKEQKPKDQSLALSPKLECSGTILAHSNLRLLGSSDSPASASRVAGITGVCHHAQDQVAGECIIEKQGRIHPDLQPHNSGSEPSLSRQRRQKRREQTEHRGEKRQVRRDLFAFQESPPRFLPSHPIVGKVDVTSTQKEAENQRRVVTGSVSSSRSSEMSSSKDRPLSARERRRLKQSQEEMSSSGPSVRKASLSVAGPGKPQEEDQPLPARRLSSDCSVTQERKQIHCLSEDELSSSTSSTDKSDGDYGEGKGQTNEINALVQLMTQTLKLDSKESCEDVPVANPVSEFKLHRKYRDTLILHGKVAEEAEEIHFKELPSAIMPGSEKIRRLVEVLRTDVIRGLGVQLLEQVYDLLEEEDEFDREVRLREHMGEKYTTYSVKARQLKFFEENMNF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Phosphorylation--MPLAAYCYLRVVG
--CCCEEEEEEEEEC
3.9724719451
8PhosphorylationMPLAAYCYLRVVGKG
CCCEEEEEEEEECCC
5.7229496907
10MethylationLAAYCYLRVVGKGSY
CEEEEEEEEECCCCC
8.46115484793
14UbiquitinationCYLRVVGKGSYGEVT
EEEEEECCCCCEEEE
32.83-
17PhosphorylationRVVGKGSYGEVTLVK
EEECCCCCEEEEEEE
26.4421964256
24UbiquitinationYGEVTLVKHRRDGKQ
CEEEEEEEECCCCCE
34.21-
30UbiquitinationVKHRRDGKQYVIKKL
EEECCCCCEEEEEEH
42.62-
43PhosphorylationKLNLRNASSRERRAA
EHHCCCCCHHHHHHH
33.21-
44PhosphorylationLNLRNASSRERRAAE
HHCCCCCHHHHHHHH
35.43-
58PhosphorylationEQEAQLLSQLKHPNI
HHHHHHHHHCCCCCE
41.9024719451
61UbiquitinationAQLLSQLKHPNIVTY
HHHHHHCCCCCEEEE
49.75-
133UbiquitinationHILHRDLKTQNVFLT
CCCCCCCCCCCEEEE
52.97-
146UbiquitinationLTRTNIIKVGDLGIA
EECCCEEEECHHHHH
36.05-
165PhosphorylationNHCDMASTLIGTPYY
HCCCHHHHHCCCCCC
16.92-
181UbiquitinationSPELFSNKPYNYKSD
CHHHHCCCCCCCCCH
47.91-
209UbiquitinationLKHAFNAKDMNSLVY
HHHHHCCCCHHHHHH
59.62-
216PhosphorylationKDMNSLVYRIIEGKL
CCHHHHHHHHHCCCC
11.03-
222UbiquitinationVYRIIEGKLPPMPRD
HHHHHCCCCCCCCCC
45.06-
243PhosphorylationELIRTMLSKRPEERP
HHHHHHHHCCCCCCC
18.79-
266PhosphorylationPYIKRQISFFLEATK
HHHHHHHHHHHHHHC
11.1223898821
273UbiquitinationSFFLEATKIKTSKNN
HHHHHHHCCCCCCCC
49.61-
273AcetylationSFFLEATKIKTSKNN
HHHHHHHCCCCCCCC
49.617298903
275AcetylationFLEATKIKTSKNNIK
HHHHHCCCCCCCCCC
48.587298911
278AcetylationATKIKTSKNNIKNGD
HHCCCCCCCCCCCCC
60.287298919
286PhosphorylationNNIKNGDSQSKPFAT
CCCCCCCCCCCCCEE
37.4418785766
289UbiquitinationKNGDSQSKPFATVVS
CCCCCCCCCCEEEEE
36.20-
319PhosphorylationSSEGSQTYIMGEGKC
CCCCCEEEEECCCEE
4.93-
335PhosphorylationSQEKPRASGLLKSPA
CCCCCCCCCCCCCHH
31.1129514088
339MethylationPRASGLLKSPASLKA
CCCCCCCCCHHHHCC
60.48115973887
339UbiquitinationPRASGLLKSPASLKA
CCCCCCCCCHHHHCC
60.48-
340PhosphorylationRASGLLKSPASLKAH
CCCCCCCCHHHHCCC
26.1822617229
343PhosphorylationGLLKSPASLKAHTCK
CCCCCHHHHCCCCCC
33.5122617229
345MethylationLKSPASLKAHTCKQD
CCCHHHHCCCCCCCC
35.31115973895
345UbiquitinationLKSPASLKAHTCKQD
CCCHHHHCCCCCCCC
35.31-
377PhosphorylationLPAKGRDSVSDGFVQ
ECCCCCCCCCCCCCC
23.3528985074
379PhosphorylationAKGRDSVSDGFVQEN
CCCCCCCCCCCCCCC
35.6529978859
442UbiquitinationGEKNEPVKPLQPLIK
CCCCCCCCCCHHHHH
51.21-
457PhosphorylationEQKPKDQSLALSPKL
CCCCCCCCCCCCCCC
26.2423401153
461PhosphorylationKDQSLALSPKLECSG
CCCCCCCCCCCCCCC
17.8723401153
467PhosphorylationLSPKLECSGTILAHS
CCCCCCCCCEEEECC
29.6030576142
469PhosphorylationPKLECSGTILAHSNL
CCCCCCCEEEECCCE
9.1227251275
474PhosphorylationSGTILAHSNLRLLGS
CCEEEECCCEEECCC
31.77-
481PhosphorylationSNLRLLGSSDSPASA
CCEEECCCCCCCHHH
30.8329255136
482PhosphorylationNLRLLGSSDSPASAS
CEEECCCCCCCHHHH
40.0729255136
484PhosphorylationRLLGSSDSPASASRV
EECCCCCCCHHHHHH
25.0629255136
487PhosphorylationGSSDSPASASRVAGI
CCCCCCHHHHHHHCH
30.1129255136
489PhosphorylationSDSPASASRVAGITG
CCCCHHHHHHHCHHC
25.4529255136
526PhosphorylationPDLQPHNSGSEPSLS
CCCCCCCCCCCCCHH
40.4328555341
533PhosphorylationSGSEPSLSRQRRQKR
CCCCCCHHHHHHHHH
30.6121712546
563PhosphorylationDLFAFQESPPRFLPS
HHHHHCCCCCCCCCC
29.4419664994
570PhosphorylationSPPRFLPSHPIVGKV
CCCCCCCCCCCEEEE
44.0023312004
576AcetylationPSHPIVGKVDVTSTQ
CCCCCEEEEECCCCH
25.1125953088
580PhosphorylationIVGKVDVTSTQKEAE
CEEEEECCCCHHHHH
22.9218669648
582PhosphorylationGKVDVTSTQKEAENQ
EEEECCCCHHHHHHC
34.0018669648
594PhosphorylationENQRRVVTGSVSSSR
HHCEEEEEECCCCCC
22.3830177828
596PhosphorylationQRRVVTGSVSSSRSS
CEEEEEECCCCCCCC
14.9530177828
598PhosphorylationRVVTGSVSSSRSSEM
EEEEECCCCCCCCCC
25.0530177828
599PhosphorylationVVTGSVSSSRSSEMS
EEEECCCCCCCCCCC
27.8430177828
600PhosphorylationVTGSVSSSRSSEMSS
EEECCCCCCCCCCCC
28.7730177828
602PhosphorylationGSVSSSRSSEMSSSK
ECCCCCCCCCCCCCC
32.3823909892
603PhosphorylationSVSSSRSSEMSSSKD
CCCCCCCCCCCCCCC
35.8929396449
606PhosphorylationSSRSSEMSSSKDRPL
CCCCCCCCCCCCCCC
27.6623909892
607PhosphorylationSRSSEMSSSKDRPLS
CCCCCCCCCCCCCCC
39.8523909892
608PhosphorylationRSSEMSSSKDRPLSA
CCCCCCCCCCCCCCH
31.1329396449
609UbiquitinationSSEMSSSKDRPLSAR
CCCCCCCCCCCCCHH
60.76-
622MethylationARERRRLKQSQEEMS
HHHHHHHHHHHHHHH
46.2024129315
622UbiquitinationARERRRLKQSQEEMS
HHHHHHHHHHHHHHH
46.20-
624PhosphorylationERRRLKQSQEEMSSS
HHHHHHHHHHHHHHC
37.6628348404
629PhosphorylationKQSQEEMSSSGPSVR
HHHHHHHHHCCCCHH
25.32-
630PhosphorylationQSQEEMSSSGPSVRK
HHHHHHHHCCCCHHE
37.69-
631PhosphorylationSQEEMSSSGPSVRKA
HHHHHHHCCCCHHEE
47.63-
634PhosphorylationEMSSSGPSVRKASLS
HHHHCCCCHHEEEEE
37.77-
637UbiquitinationSSGPSVRKASLSVAG
HCCCCHHEEEEEECC
39.92-
639PhosphorylationGPSVRKASLSVAGPG
CCCHHEEEEEECCCC
24.9823401153
641PhosphorylationSVRKASLSVAGPGKP
CHHEEEEEECCCCCC
13.8728450419
647UbiquitinationLSVAGPGKPQEEDQP
EEECCCCCCCCCCCC
46.81-
647AcetylationLSVAGPGKPQEEDQP
EEECCCCCCCCCCCC
46.8130590727
661PhosphorylationPLPARRLSSDCSVTQ
CCCCHHHCCCCCCCC
23.4827273156
662PhosphorylationLPARRLSSDCSVTQE
CCCHHHCCCCCCCCH
47.4229255136
665PhosphorylationRRLSSDCSVTQERKQ
HHHCCCCCCCCHHHH
32.9429255136
667PhosphorylationLSSDCSVTQERKQIH
HCCCCCCCCHHHHEE
14.3929978859
677PhosphorylationRKQIHCLSEDELSSS
HHHEEECCHHHHCCC
48.6929255136
682PhosphorylationCLSEDELSSSTSSTD
ECCHHHHCCCCCCCC
21.8629978859
684PhosphorylationSEDELSSSTSSTDKS
CHHHHCCCCCCCCCC
29.0023898821
690UbiquitinationSSTSSTDKSDGDYGE
CCCCCCCCCCCCCCC
51.00-
691PhosphorylationSTSSTDKSDGDYGEG
CCCCCCCCCCCCCCC
50.03-
699UbiquitinationDGDYGEGKGQTNEIN
CCCCCCCCCHHHHHH
43.47-
702PhosphorylationYGEGKGQTNEINALV
CCCCCCHHHHHHHHH
43.4122199227
721UbiquitinationQTLKLDSKESCEDVP
HCCCCCCCCCCCCCC
54.00-
723PhosphorylationLKLDSKESCEDVPVA
CCCCCCCCCCCCCCC
26.92-
737UbiquitinationANPVSEFKLHRKYRD
CCCCCCCCCCHHHCC
39.05-
745PhosphorylationLHRKYRDTLILHGKV
CCHHHCCEEEEECCC
13.4928555341
751UbiquitinationDTLILHGKVAEEAEE
CEEEEECCCHHHHHH
27.76-
762UbiquitinationEAEEIHFKELPSAIM
HHHHHCCCCCCCCCC
44.15-
766O-linked_GlycosylationIHFKELPSAIMPGSE
HCCCCCCCCCCCCHH
42.9528411811
772PhosphorylationPSAIMPGSEKIRRLV
CCCCCCCHHHHHHHH
29.8224719451
826PhosphorylationGEKYTTYSVKARQLK
CCCEEEEEEEHHHHH
18.3030631047
828UbiquitinationKYTTYSVKARQLKFF
CEEEEEEEHHHHHHH
31.73-
833UbiquitinationSVKARQLKFFEENMN
EEEHHHHHHHHHHCC
39.40-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of NEK4_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NEK4_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NEK4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TBA3C_HUMANTUBA3Cphysical
27173435
TBB1_HUMANTUBB1physical
27173435
FTM_HUMANRPGRIP1Lphysical
27173435
CTNA1_HUMANCTNNA1physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NEK4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-563, AND MASSSPECTROMETRY.

TOP